본문 바로가기

Efficacy and safety of glimepiride/metformin sustained release once daily vs. glimepiride/metformin twice daily in patients with type 2 diabetes

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE67(3) · pp.236 · 2013
피인용
Web of Science 8
JCR IF
JCR 2012 2.427
ISSN
1368-5031

저자

  1. Hwang, Y. C.제1저자Department Internal Medicine, Kyung Hee University, Kyung Hee University Hospital, South Korea
  2. Kang, M.Center for Health Promotion, Samsung Medical Center, South Korea
  3. Ahn, C. W.Department of Internal Medicine, Yonsei University, South Korea
  4. Park, J. S.Department of Internal Medicine, Yonsei University, South Korea
  5. Baik, S. H.Department of Internal Medicine, College of Medicine, Korea University, South Korea
  6. Chung, D. J.Department of Internal Medicine, Chonnam National University, Medical School, South Korea
  7. Jang, H. C.Department of Internal Medicine, Seoul National University, Bundang Hospital, South Korea
  8. Kim, K. A.Department of Internal Medicine, University of Dongguk, Ilsan Hospital, South Korea
  9. Lee, I. K.Department of Internal Medicine, Kyungpook National University, School of Medicine, South Korea
  10. Min, K. W.Department of Internal Medicine, Eulji University, College of Medicine, South Korea
  11. Nam, M.Department of Internal Medicine, Inha University, College of Medicine, South Korea
  12. Park, T. S.Department of Internal Medicine, Chonbuk National University, Medical School, South Korea
  13. 손석만Department of Internal Medicine, School of Medicine, Pusan National University, South Korea
  14. Sung, Y. A.Department of Internal Medicine, College of Medicine, Ewha Womans University, South Korea
  15. Woo, J. T.Department of Endocrinology and Metabolism, Kyung Hee University, School of Medicine, South Korea
  16. Park, K. S.Department of Internal Medicine, Seoul National University, College of Medicine, South Korea
  17. Lee, M. K.교신저자Department of Medicine, School of Medicine, Sungkyunkwan University, South Korea

초록

Aims: The study investigated the clinical equivalence in reducing haemoglobin A1c (A1C) between glimepiride/metformin sustained release (GM-SR) 2/500mg, a fixed-dose combination, once daily and glimepiride/metformin (GM) 1/250mg, a fixed-dose combination, twice daily in patients with type 2 diabetes (T2D). Methods: A multicentre, randomised, double-blind, double-dummy study was conducted in 14 hospitals in Korea. Inclusion criteria were age 3075years, T2D diagnosis no longer than 10years previously, A1C between 7% and 10%, and body mass index <40kg/m2. A total of 207 subjects were randomised into the GM-SR group (n=101) or the GM group (n=106). Participants were assessed at baseline, 8weeks and 16weeks after treatment. Results: After 16weeks treatment, no difference in baseline-adjusted changes of A1C (primary efficacy variable) was observed between the two groups (0.59% for GM-SR group vs. 0.61% for GM group, 95% CI: 0.17 to 0.21; p=0.84). In addition, there were no significant differences in secondary efficacy parameters between the two groups, including changes in A1C up to week 8, changes in fasting plasma glucose (FPG) and 2-h-postprandial plasma glucose up to week 8 and week 16, response rate, drug compliance and hypoglycaemic events. However, there was a difference in baseline-adjusted changes of FPG between the two groups (1.01mmol/l for GM-SR group vs. 1.52mmol/l for GM group, p=0.01 in the intention to treat set). Conclusions: GM-SR 2/500mg once daily was as effective as GM 1/250mg twice daily in lowering A1C. In addition, no difference was noted in hypoglycaemic events between the two groups.

키워드

IMPROVED GLYCEMIC CONTROLBLOOD-GLUCOSE CONTROLSULFONYLUREA TREATMENTMETFORMINMELLITUSTHERAPYINSULINCOMPLICATIONSMONOTHERAPYHYPERGLYCEMIA

식별자

WoS UID
000315117700009